SEI Investments’s Tarsus Pharmaceuticals TARS Stock Holding History

SEI Investments’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Sell	24,843 -6,232	-20%	-$398K	﹤0.01%	2077
2026 Q1	$2.18M	Sell	31,075 -12,269	-28%	-$857K	﹤0.01%	1965
2025 Q4	$3.55M	Buy	43,344 +11,764	+37%	+$878K	﹤0.01%	1550
2025 Q3	$1.88M	Buy	31,580 +1,522	+5%	+$74.9K	﹤0.01%	1720
2025 Q2	$1.22M	Sell	30,058 -7,313	-20%	-$329K	﹤0.01%	1840
2025 Q1	$1.92M	Sell	37,371 -10,809	-22%	-$534K	﹤0.01%	1654
2024 Q4	$2.67M	Buy	48,180 +12,689	+36%	+$576K	﹤0.01%	1567
2024 Q3	$1.17M	Buy	35,491 +14,193	+67%	+$399K	﹤0.01%	1898
2024 Q2	$579K	Sell	21,298 -11,506	-35%	-$387K	﹤0.01%	2104
2024 Q1	$1.19M	Buy	32,804 +18,426	+128%	+$542K	﹤0.01%	1817
2023 Q4	$291K	Sell	14,378 -49,235	-77%	-$822K	﹤0.01%	2317
2023 Q3	$1.13M	Buy	+63,613	New	+$1.13M	﹤0.01%	1842

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SEI Investments's TARS Position: Q2 2026 in Review

SEI Investments reduced its Tarsus Pharmaceuticals (TARS) stake by 20% in Q2 2026, selling an estimated $398K and leaving 24,843 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

SEI Investments first reported a position in TARS in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.55M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

SEI Investments held 24,843 shares of Tarsus Pharmaceuticals worth $1.56M as of Q2 2026.
SEI Investments sold 6,232 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $398K.
Tarsus Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2077 holding.
SEI Investments first reported a position in Tarsus Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
SEI Investments's Tarsus Pharmaceuticals position peaked at $3.55M in Q4 2025.
257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.